Transforming growth factor-β1 and epidermal growth factor decrease the expression of 17β-hydroxysteroid dehydrogenase type 2 in endometrial carcinoma cells

Chinese Science Bulletin

Volumn 47, Issue 1, 2002, Pages 44-47

  Li, Xiaohong ^a   Xiao, Zhijie ^a   Piao, Yunshang ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

17 hydroxysteroid dehydrogenase; Endometrium; Estrogen; Growth factor

Indexed keywords

EPIDERMAL GROWTH FACTOR; ESTRADIOL; ESTROGEN RECEPTOR; ESTRONE; MESSENGER RNA; TESTOSTERONE 17BETA DEHYDROGENASE; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; ENDOMETRIUM CARCINOMA; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0036093248     PISSN: 10016538     EISSN: None     Source Type: Journal    
DOI: 10.1360/02tb9008     Document Type: Article

References (15)

1. Intracrinology
2. 17 β-hydroxysteroid dehydrogenase/17-ketosteroid reductase family: Nomenclature and main characteristics of the 17hsd/ksr enzymes
3. Human 17 β-hydroxysteroid dehydrogenase type 1 and type 2 isoenzymes have opposite activities in cultured cells and characteristic cell- and tissue-specific expression
4. Human 17 β-hydroxysteroid dehydrogenase type 2 messenger ribonucleic acid expression and localization in term placenta and in endometrium during the menstrual cycle
5. Hormonal aspects of endometrial cancer
6. Biology of female sex hormone action in relation to contraceptive agents and neoplasia
7. Immunohistochemical localization of 17 β-hydroxysteroid dehydrogenase (17HSD) in the human endometrium during the menstrual cycle
8. 17 β-hydroxysteroid dehydrogenase type 2: Chromosomal assignment and progestin regulation of gene expression in human endometrium
9. Changes in vitro metabolism of estradiol by human endometrium during the menstrual cycle
10. Characterization of a new human endometrial carcinoma (RL95-2) established in tissue culture
11. Retinoic acids increase 17 β-hydroxysteroid dehydrogenase type 1 expression in JEG-3 and T47d cells, but the stimulation is potentiated by epidermal growth factor, 12-O-tetradecanoulphorbol-13-acetate, and cyclic adenosine 3′,5′-monophosphate only in JEG-3 cells
12. Autocrine and paracrine effects in the endometrium
13. Growth factors in the human endometrium
14. Regulation of 17β-hydroxysteroid dehydrogenase type 1 by epidermal growth factor and transforming growth factor alpha in choriocarcinoma cells
15. Immunohistochemical study of the human 17β-hydroxysteroid dehydrogenase and steroid receptors in endometrial adenocarcinoma